#USA #Dental Solutions #San Clemente #Angelalign Technology #Clear-Aligners

Angelalign Technology Reports Strong First Half Results

On August 26, 2025, Angelalign Technology Inc. (HK: 6699), known simply as Angel, released its interim results for the first half of 2025, showcasing a remarkable 33.1% increase in revenue compared to the previous year. With earnings amounting to $161.4 million and a gross profit of $100.6 million, the company also achieved a net profit of $19.5 million. This growth can be attributed to the volume of clear aligner treatments, which dramatically rose by 47.7%, totaling approximately 225,800 cases worldwide.

Key Results and Growth Factors

Angelalign's success in the first half of the year resulted from efficient operations in its treatment planning centers and transparent aligner production facilities. Beyond sales growth, strategic cost management has led the company to navigate a volatile tariff environment by delaying the onboarding of certain employees in sales, clinical support, and customer service. Additionally, operational delays at their overseas planning and production sites contributed to the solid financial performance.

To solidify its international presence, Angel plans to increase long-term investments across pivotal sectors. Investments in sales and marketing will be heightened, alongside enhancements in clinical support and customer service. Plans to establish and operate treatment planning centers and production facilities outside of mainland China are also underway. Furthermore, the company is enhancing its legal capabilities to safeguard intellectual property rights and ensure regulatory compliance while boosting its data security infrastructure.

Regional Growth Highlights

Remarkably, Angel's case volume in markets outside mainland China surged by 103.5% compared to the previous year, reaching 117,200 cases. The growth is reflective of an initially low base last year and successful entry into new markets. Angel's increased footprint can be credited to high-quality treatment planning, consistent delivery capabilities, and continuous training programs with key opinion leaders (KOLs). Within mainland China, case volume grew by 14%, totaling around 108,600 cases, as the company pursues an innovative growth strategy that emphasizes early orthodontic treatment and emerging markets as key drivers for sustainable development.

In the first half of 2025, Angelalign introduced innovative products and solutions focused on early orthodontic treatment, integrating intelligent initial consultation tools and treatment monitoring within its offerings. Collaborative research with various universities has also been initiated to propel clinical innovation.

Commitment to Intellectual Property and Compliance

The company's IP strategy and compliance efforts remain high priorities. As part of its global expansion strategy, Angelalign has significantly bolstered its legal resources. They plan to continue their tradition of innovation while vigorously defending intellectual property rights.

In response to growing market demands, Angelalign is developing a world-class smart manufacturing system that emphasizes user orientation, ecological sustainability, and scalability. The company intends to establish or expand production and treatment planning facilities at key global locations to assure timely and stable product and service provisions to customers worldwide. The treatment planning centers in Brazil and Southeast Asia are already providing planning services for the U.S. market.

Additionally, Angelalign has invested considerable resources to enhance its data security infrastructure and operational processes, ensuring compliance with data security and privacy regulations across all significant markets. This represents a significant ongoing commitment.

Looking Ahead

Fox Hu, CEO of Angelalign, conveyed confidence regarding the long-term growth prospects of the global clear aligner market. Major priorities include scaling aligner and treatment planning production, enhancing clinical capabilities, continuing product innovation while safeguarding IP rights, increasing compliance investments, and promoting sustainable growth across all regions.

Founded in 2003, Angelalign Technology Inc. has successfully helped 1.5 million individuals achieve beautiful smiles. The company offers digital, tech-driven products and services in clear aligners that cater to the needs of dentists and patients globally. Its innovative approach has positioned Angelalign as a leader in the orthodontic industry. In 2021, it was listed on the Hong Kong Stock Exchange, and by 2023, Angelalign started its global expansion strategy, with its products and services now available in over 50 countries and regions. For more information, visit angelaligner.com.